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Abstract
Background: The apoptotic speck-like protein containing a caspase recruitment domain (ASC) is the essential adaptor 
protein for caspase 1 mediated interleukin (IL)-1β and IL-18 processing in inflammasomes. It bridges activated Nod like 
receptors (NLRs), which are a family of cytosolic pattern recognition receptors of the innate immune system, with 
caspase 1, resulting in caspase 1 activation and subsequent processing of caspase 1 substrates. Hence, macrophages 
from ASC deficient mice are impaired in their ability to produce bioactive IL-1β. Furthermore, we recently showed that 
ASC translocates from the nucleus to the cytosol in response to inflammatory stimulation in order to promote an 
inflammasome response, which triggers IL-1β processing and secretion. However, the precise regulation of 
inflammasomes at the level of ASC is still not completely understood. In this study we identified and characterized 
three novel ASC isoforms for their ability to function as an inflammasome adaptor.
Methods: To establish the ability of ASC and ASC isoforms as functional inflammasome adaptors, IL-1β processing and 
secretion was investigated by ELISA in inflammasome reconstitution assays, stable expression in THP-1 and J774A1 
cells, and by restoring the lack of endogenous ASC in mouse RAW264.7 macrophages. In addition, the localization of 
ASC and ASC isoforms was determined by immunofluorescence staining.
Results: The three novel ASC isoforms, ASC-b, ASC-c and ASC-d display unique and distinct capabilities to each other 
and to full length ASC in respect to their function as an inflammasome adaptor, with one of the isoforms even showing 
an inhibitory effect. Consistently, only the activating isoforms of ASC, ASC and ASC-b, co-localized with NLRP3 and 
caspase 1, while the inhibitory isoform ASC-c, co-localized only with caspase 1, but not with NLRP3. ASC-d did not co-
localize with NLRP3 or with caspase 1 and consistently lacked the ability to function as an inflammasome adaptor and 
its precise function and relation to ASC will need further investigation.
Conclusions: Alternative splicing and potentially other editing mechanisms generate ASC isoforms with distinct 
abilities to function as inflammasome adaptor, which is potentially utilized to regulate inflammasomes during the 
inflammatory host response.
Background
Inflammasomes are inducible multi-protein platforms in
phagocytic cells that are required for activation of cas-
pase 1 by induced proximity during the inflammatory
host response following pathogen infection and tissue
damage [1]. The best characterized substrates for caspase
1 are interleukin (IL)-1β and IL-18, two potent pro-
inflammatory cytokines [2]. However, a number of alter-
native substrates have been recently identified [3,4].
While generation of bioactive IL-1β and IL-18 is regu-
lated at multiple steps, including transcription, posttrans-
lational processing and receptor binding [2], their
maturation into the bioactive secreted 17 and 18 kDa
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forms is dependent on the proteolytically active caspase 1
[5,6]. Inflammasomes are activated in response to the
recognition of damage-associated molecular patterns
(DAMPs) derived from pathogens (PAMPs) or host (dan-
ger or stress signals) by members of the cytosolic Nod-
like receptor (NLR) family of cytosolic pattern recogni-
tion receptors (PRRs) [6-10]. The largest subfamily of
NLRs contains a PYRIN domain (PYD) as an effector
domain [11]. Activated NLRs undergo NTP-dependent
oligomerization in response to DAMP recognition, and
recruit the essential adaptor protein ASC by PYD-PYD
interaction [12,13]. ASC subsequently bridges to caspase
1 through caspase recruitment domain (CARD)-CARD
interaction [14,15]. Macrophages with ASC gene deletion
are impaired in their ability to form inflammasomes and
activate caspase 1 in response to a number of DAMPs,
underscoring the critical role of ASC as an adaptor pro-
tein linking activated NLRs to caspase 1 [16-18]. Recently,
pyrin has also been implicated in assembling an inflam-
masome, and the cytosolic DNA sensor AIM2 forms a
caspase 1 activating inflammasome, too [19-23].
IL-1β and IL-18 have a central role in the inflammatory
host response. However, dysregulation of the inflam-
masome complex causes their uncontrolled and excessive
secretion, and is directly linked to an increasing number
of human inflammatory diseases. NLRP1 polymorphisms
are linked with autoimmune diseases that cluster with
vitiligo, including autoimmune thyroid disease, latent
autoimmune diabetes, rheumatoid arthritis, psoriasis,
pernicious anemia, systemic lupus erythematosus, and
Addison's disease [24]. NLRP3-containing inflam-
masomes are linked to contact hypersensitivity, sunburn,
essential hypertension, gout and pseudogout, Alzheimer's
disease, and elevated expression of NLRP3 is detected in
synovial fluids of RA patients [25-30]. Furthermore,
hereditary mutations in NLRP3 rendering the protein
constitutively active, are directly linked to cryopyrin-
associated periodic syndromes (CAPS) [31,32]. Heredi-
tary mutations in pyrin, the causative for Familial Medi-
terranean fever (FMF) and in PSTPIP1, a pyrin
interacting protein responsible for Pyogenic arthritis,
pyoderma gangrenosum, and acne syndrome (PAPA), are
responsible for impaired regulation of IL-1β maturation
[33-35]. Mutant NLRP3 proteins efficiently form com-
plexes with ASC to mediate caspase 1 activation indepen-
dent of an activating ligand. This finding demonstrates
the potential benefits of controlling the recruitment of
ASC to NLRs.
Several molecular mechanisms have been linked to
control inflammasome activation, including single PYD
or CARD-containing proteins, pyrin and some NLRs
[36]. We recently demonstrated that upon infections and
cell stress conditions, such as treatment of cells with bac-
terial RNA or heat killed gram positive and gram negative
bacteria, ASC redistributes from the nucleus to the cyto-
sol, where it aggregates with NLRs and caspase 1 into
perinuclear structures [37]. Sequestering ASC inside the
nucleus completely prevented caspase 1 activation and
processing and release of IL-1β, suggesting that redistri-
bution of ASC might function as a check-point to prevent
spontaneous and unwanted inflammasome activation.
Here we report on the identification of three ASC iso-
forms with distinct abilities to function as inflammasome
adaptor, suggesting that differential splicing of the ASC
pre-mRNA might potentially modulate the inflammatory
host responses at the level of inflammasomes.
Methods
Materials and Reagents
Monoclonal ASC-PYD-specific antibodies were from
MBL (D086-3, clone 23-4, 1:1000), rabbit polyclonal
ASC-PYD-specific antibodies recognizing mouse ASC
were from Alexis (AL177, 1:500) and ASC-CARD-spe-
cific antibodies were from Chemicon (AB3607, 1:500),
and rabbit polyclonal ASC-Linker-specific antibodies
were custom raised (CS3 1:10,000) using the peptide
CGSGAAPAGIRAPPQSAAKPG corresponding to
amino acids 93-111 of human ASC [37].
Expression Plasmids
A search of the publicly available expressed sequence tag
(EST) database revealed three potential ASC isoforms:
ASC-b (Acc. No. BM456838), ASC-c (Acc. No.
BE560228), and ASC-d (Acc. No. BM920038). The com-
plete open reading frame of each isoform was subse-
quently amplified by PCR from pooled THP-1 cell
cDNAs that were induced with a cocktail of cytokines for
2 to 24 hours. ASC-b, ASC-c, and ASC-d were amplified
using the common forward primer 5'-CGGAATTC-
GATCCTGGAGCCATGGG-3' and the common reverse
primer 5'-CGCTCGAGTGACCGGAGTGTTGCTG-3'
and cloned into a modified pcDNA3 vector (Invitrogen)
in frame with an NH2-terminal myc epitope tag. The
CARD of caspase 1 was amplified by high fidelity PCR
and cloned into pGex4T-1 (Novagen). All other expres-
sion constructs (ASC, pro-IL-1β, pro-caspase 1,
NLRP3R260W) have been previously described [37-39].
RT-PCR
THP-1 cells were differentiated into adherent mac-
rophages by o/n culture in complete medium supple-
mented with 25 ng/ml phorbol 12-myristate 13-acetate
(PMA; Calbiochem) and further cultured for 2 days, fol-
lowed by treatment with LPS as indicated. Total RNA was
isolated using Trizol (Invitrogen), reverse transcribed
into cDNA (Superscript III, Invitrogen) and analyzed for
ASC mRNA expression by RT-PCR using the followingBryan et al. Journal of Inflammation 2010, 7:23
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primer pairs: pr-1: 5'-GCTGTCCATGGACGCCTTGG-
3', 5'-CATCCGTCAGGACCTTCCCGT-3' (ASC: 299 bp,
ASC-b: 242 bp); pr-2: 5'-GCCATCCTGGATGCGCTG-
GAG-3', 5'-GGCCGCCTGCAGCTTGAAC-3' (ASC-c:
66 bp); pr-3: 5'-CTGACCGCCGAGGAGCTCAA-
GAAGT-3', 5'-GGCGCCGTAGGTCTCCAGGTA-
GAAG-3' (ASC and ASC-b: 128 bp, ASC-d: 100 bp); β
actin 5'-GGATGGCATGGGGGAGGGCATA-3', 5'-
TGATATCGCCGCGCTCGTCGTC-3' (533 bp).
Cell Culture
HEK293, RAW264.7, THP-1 and J774A1 cells were
obtained from the American Type Culture Collection
(ATCC) and maintained in DMEM supplemented with
10% FBS, 4 mM L-glutamine, 0.1 mM non-essential
amino acids, 1 mM sodium pyruvate, 1.5 g/L sodium
bicarbonate, and 1% penicillin/streptomycin antibiotics
(HEK293, RAW264.7, J774A1) or RPMI medium (ATCC)
containing 2 mM L-glutamine, 10 mM HEPES, 1 mM
sodium pyruvate, 4500 mg/l glucose, supplemented with
1500 mg/l sodium bicarbonate, 0.05 mM 2-mercaptoeth-
anol and 10% FBS (THP-1). Human peripheral blood
mononuclear cells (PBMC) were isolated by Ficoll-
Hypaque centrifugation (Sigma) from buffy coats
obtained from healthy donors and countercurrent cen-
trifugal elutriation in the presence of 10 μg/ml polymyxin
B sulfate using a JE-6B rotor (Beckman Coulter). PBMC
w e r e  w a s h e d  i n  H a n k ' s  B u f f e r e d  S a l t  S o l u t i o n ,  r e s u s -
pended in serum-free DMEM for 1 hour and then cul-
tured in complete medium supplemented with 20% FBS
for 7 days to differentiate peripheral blood macrophages
(PBM). HEK293 cells were transiently transfected using
Polyfect (Qiagen) or Xfect (Clontech) according the pro-
cedures recommended by the manufacturer.
Stable Cells
RAW264.7 were stably transfected with linearized
expression vectors using the Amaxa Nucleofector using
program H-033, 2 × 106 cells and 1.75 μg DNA, and
selected with 1 mg/ml G418 for 14 days and tested for
expression by immunoblot and immunofluorescence.
Stable ASC-c expressing THP-1 and J774A1 cells were
generated by lentivirus transduction. ASC-c was shuttled
into the pLEX expression plasmid (Open Biosystems)
modified to contain Myc or GFP epitope tags. Lentivirus
was produced by co-expression of pLEX with pMD2.G
and psPAX2 (Addgene plasmids 12259 and 12260) in 12-
well dishes and 250 μl clarified culture supernatant was
used to transduce 105 THP-1 and J774A1 cells using 4 μg/
ml Polybrene and the ExpressMag transduction enhanc-
ing system (Sigma) in 96-well dishes for 4 hours at 32°C,
followed by Puromycin selection.
Immunofluorescence
HEK293 cells were seeded onto Type I collagen-coated (5
μg/cm2) glass cover slips in 6-well plates. The following
day they were transfected with plasmids encoding each of
the ASC isoforms alone or co-transfected with GFP-
NLRP3R260W, GFP-pro-caspase 1C285A, or HA-tagged
ASC. 36 hours post-transfection, cells were fixed in 3.7%
paraformaldehyde, incubated in 50 mM glycine for 5
minutes and permeabilized and blocked with 0.5%
saponin, 1.5% BSA, 1.5% normal goat serum for 30 min-
utes. Immunostaining was performed with polyclonal
anti-myc or HA antibodies (Santa Cruz Biotechnology,
1:400) or monoclonal anti-myc antibodies (Santa Cruz
Biotechnology, 1:400; Northwestern University Monoclo-
nal Antibody Facility, 1:10,000). Secondary Alexa Fluor
488 and 546-conjugated antibodies, Topro-3, DAPI, and
phalloidin were from Molecular Probes. Cells were
washed with PBS containing 0.5% saponin, and cover
slips were mounted using Fluoromount-G (Southern Bio-
tech). Images were acquired by confocal laser scanning
microscopy on a Zeiss LSM 510 Meta and epifluores-
cence microscopy on a Nikon TE2000E2 with a 100× oil
immersion objective and image deconvolution (Nikon
Elements). Presented are representative results observed
in the majority of cells from several repeats.
Subcellular fractionation
106 cells were resuspended in hypotonic lysis buffer (10
mM Tris-HCL pH 7.4, 10 mM NaCl, 3 mM MgCl2, 1 mM
EDTA, and 1 mM EGTA, supplemented with protease
and phosphatase inhibitors), incubated on ice, adjusted to
250 mM sucrose, and lysed using a Dounce homogenizer.
Samples were initially centrifuged at 4°C at 1,000 × g for 3
minutes to remove any intact cells and then centrifuged
at 4°C at 2,000 × g for 10 minutes to pellet the nuclei. The
cytosolic supernatant was removed, and the nuclear pel-
let was then washed three times in hypotonic lysis buffer
with the addition of 250 mM sucrose and 0.1% NP-40 and
incubated for 20 minutes on ice. Both fractions were
adjusted to 50 mM Tris-HCl pH 7.4, 20 mM NaCl, 3 mM
MgCl2, 250 mM sucrose, 0.5% deoxycholate, 0.1% SDS,
0.2% NP-40, and protease and phosphatase inhibitors,
and fully solubilized by brief sonication. 50 μg of protein
lysates were separated by SDS-PAGE, transferred to a
PVDF membrane, and probed with anti-ASC antibodies
and HRP-conjugated secondary antibodies (Amersham
Pharmacia) in conjunction with an ECL detection system
(Pierce). Membranes were stripped and re-probed with
anti-GAPDH (Sigma) and anti-Lamin A (Santa Cruz Bio-
technology) antibodies as control for cytosolic and
nuclear fractions, respectively.Bryan et al. Journal of Inflammation 2010, 7:23
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Measurement of IL-1β secretion
HEK293 cells were seeded into type-I collagen-coated 12-
well dishes, and allowed to attach overnight. Cells were
co-transfected in triplicates the following day with
expression constructs encoding the constitutively active
NLRP3R260W  (0.675 μg), pro-caspase 1 (0.15 μg), and
mouse pro-IL-1β (0.375 μg), and each of the ASC iso-
forms ASC-b, -c, or -d (0.04 μg) or ASC (0.015 μg), either
alone or in the presence of full-length ASC to reconsti-
tute inflammasomes. The total amount of DNA was kept
constant with the addition of an empty pcDNA3 vector as
necessary. The media was replaced 24 hours post-trans-
fection, and at 48 hours post transfection, the superna-
tants were collected, clarified by centrifuged at 13,000
rpm for 15 minutes at 4°C, and analyzed by ELISA for
mouse IL-1β release according to the manufacturer's pro-
tocol (BD Biosciences). RAW 264.7Ctrl, RAW 264.7ASC,
RAW 264.7ASC-b, J774A1Ctrl, J774A1ASC-c, THP-1Ctrl,
THP-1ASC-C#1, and THP-1ASC-c#2 cells were seeded into
24-well dishes and either left untreated or treated with
300 ng/ml LPS (E. coli, 0111:B4) for 16 hours followed by
the collection of culture supernatants (THP-1 cells), or
followed by pulsing with ATP (5 mM for RAW264.7 and 3
mM for J774A1 cells) for 15 minutes and collection of
culture supernatants. Clarified culture supernatants were
analyzed for secreted mouse (RAW264.7, J774A1) or
human (THP-1) IL-1β by ELISA (BD Biosciences)
according to the manufacturer's protocol.
In vitro protein-interaction assay
ASC and ASC-b were in vitro translated and biotinylated
using the TNT Quick Coupled Transcription/Translation
system (Promega) according to the manufacturer's proto-
col. GST-caspase 1-CARD was affinity purified from E.
coli  BL21, following induction with 1 mM IPTG for 4
hours at room temperature. Cells were resuspended in
STS buffer (10 mM Tris pH 8.0, 1 mM EDTA, and 150
mM NaCl), lysed by several rapid freeze/thaw cycles fol-
lowed by the addition of lysozyme (1 mg/ml). After a 30
minute incubation on ice, 10 mM DTT and 1.4% sodium
sarkosyl were added, sonicated and cleared by centrifuga-
tion at 13,000 rpm for 15 minutes. Cleared lysates were
adjusted to 4% Triton X-100 and incubated with immobi-
lized glutathione sepharose (Pierce) overnight at 4°C.
Beads were washed three times with 0.1% Triton X-100 in
PBS, blocked for 30 minutes at room temperature in
HKMEN buffer (142.4 mM KCl, 5 mM MgCl2, 10 mM
HEPES (pH 7.4), 0.5 mM EGTA, 1 mM EDTA, 0.2% NP-
40, 1 mM DTT) supplemented with protease inhibitors
and BSA (1 mg/ml). Following one wash with HKMEN
buffer, beads were incubated overnight on a rotator with
in vitro translated ASC and ASC-b. Bound proteins were
washed 4 times in HKMEN buffer supplemented with
protease inhibitors, boiled in Laemmli buffer, separated
by SDS/PAGE, transferred onto a PVDF membrane, and
detected with Streptavidin-HRP in conjugation with an
enhanced chemiluminescent reagent (Millipore).
Results
Identification of three novel ASC transcripts
We recently demonstrated that ASC localizes to the
nucleus of resting macrophages and that inflammatory
activation causes the inducible redistribution of ASC to
the cytosol [37]. We consistently noted that a monoclonal
ASC specific antibody directed to the PYD of ASC also
specifically recognizes a protein with slightly lower
molecular weight in the cytosol also in resting mac-
rophages, which we named ASC-b (Figure 1A). The
m o l e c u l a r  w e i g h t  a p p e a r e d  t o o  l a r g e  t o  c o r r e s p o n d  t o
one of the PYD-only proteins (POPs), which others and
we identified as negative regulators of inflammasomes,
and especially POP1 shares a high sequence similarity
with ASC [36,38-42]. We used a panel of commercially
available ASC specific antibodies that are directed to
either the PYD or the CARD, and raised a custom poly-
clonal antibody to the linker domain to further character-
ize this protein. Using this strategy, we identified that the
smaller protein is recognized by PYD and CARD specific
antibodies, but that our linker specific antibody fails to
detect the smaller protein in total protein lysates of THP-
1 cells, suggesting that the linker that connects the PYD
and the CARD in ASC is lacking in the smaller protein
(Figure 1B). Furthermore, a polyclonal antibody raised
against amino acid residues 2 to 27 of the PYD of ASC
also detects ASC and ASC-b in lysates of PMA-differenti-
ated THP-1 cells and an additional low abundant protein,
which we named ASC-c (Figure 1C). This antibody also
detects ASC in mouse J774A1 macrophages, which
appear to lack ASC-b, but express significant levels of a
putative ASC-c (Figure 1C). Also human peripheral blood
macrophages (PBM) express ASC-b, which is upregulated
following LPS treatment (Figure 1D). We did not detect
ASC-c under the tested conditions, but PBM express sig-
nificant lower ASC levels compared to THP-1 cells, and
thus ASC-c might have gone undetected. ASC is encoded
from three exons, and we therefore mined the publicly
available EST database to potentially identify ASC alter-
native transcripts. We identified three distinct transcripts
of ASC in addition to the full-length transcript expressed
in human tissues. Based on these sequences, we designed
specific PCR primers, and amplified all three cDNAs
from a pooled human THP-1 cell cDNA library. We
referred to these cDNAs as ASC-b, ASC-c, and ASC-d.
ASC-b was already annotated within the NCBI GenBank
and has recently been characterized as vASC by Matsush-
ita and colleagues during the preparation of our manu-
script [43]. We confirmed existence of these transcripts
by RT-PCR using total RNA isolated from THP-1 cells,Bryan et al. Journal of Inflammation 2010, 7:23
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which we differentiated into adherent macrophage-like
cells by incubation with PMA and treatment with LPS. In
resting cells transcripts for ASC, ASC-b, and very low
transcript numbers of ASC-d were present. LPS treat-
ment caused the appearance of ASC-c (Figure 1E), sug-
gesting that the presence of distinct combinations of ASC
splice variants might potentially affect inflammasome
activity at different stages of the inflammatory response.
ASC-b lacks amino acids 93 to 111, corresponding to
the entire linker region, resulting in a protein with a
directly fused PYD and CARD (Figure 2A, B). ASC-c
lacks amino acids 26 to 85 corresponding to helices 3 to 6
of the ASC-PYD, but retains an intact ASC-Linker-
CARD region (Figure 2A, B). ASC-d lacks nucleotides
107 to 134, which causes a frame shift and results in a
protein consisting of helices 1 and 2 (amino acids 1-35) of
the ASC-PYD fused to a novel 69 amino acid peptide
without recognizable homology to any other known pro-
tein (Figure 2A, B). ASC and the three alternative cDNAs
encode proteins of the predicted molecular weight, when
expressed in HEK293 cells (Figure 2C). The ASC proteins
that are abundantly expressed in THP-1 cells and are rec-
ognized by the ASC specific antibodies directed towards
the PYD and CARD of ASC are ASC and ASC-b, while
mouse J774A1 macrophages predominantly express ASC
and a putative ASC-c.
At least two of the three alternative transcripts, ASC-b
and ASC-c are likely generated through alternative
mRNA splicing. The linker is encoded on exon 2 and is
flanked by splice donor and acceptor sites. ASC-c likely
utilizes an alternative 3' and 5' splice site and contains a
potential splice acceptor site and a less conserved splice
donor site. Generation of ASC-d could involve RNA edit-
ing, but its relationship to ASC and its generation and
function in inflammasome regulation will need further
investigations, due to its limited homology to ASC.
ASC, ASC-b, ASC-c and ASC-d display distinct localization 
patterns
Ectopic expression of ASC displays a very characteristic
localization pattern. It either localizes to the nucleus,
diffusively throughout the cell, or to a perinuclear aggre-
gate [44-46]. However, we recently demonstrated that this
localization pattern is neither random nor caused by over
expression of ASC, but that a similar distribution is also
found for endogenous ASC, which is nuclear in resting
macrophages, but is redistributed to cytoplasmic perinu-
clear aggregates in response to inflammatory activation
of macrophages [37]. Therefore we investigated the local-
ization patterns of the three alternate ASC proteins.
Expression plasmids encoding each of the ASC isoforms
were transiently transfected into HEK293 cells, and their
subcellular distribution was analyzed by immunofluores-
cence microscopy. As previously reported, expression of
full-length ASC resulted in the formation of the perinu-
clear aggregate (Figure 3, 1st panel) or localization to the
nucleus (Figure 3, 2nd panel). However, none of the other
isoforms retained the capacity to form these structures,
but rather exhibited their own, unique localization pat-
tern. ASC-b displayed a diffuse, exclusively cytoplasmic
Figure 1 Identification of ASC isoforms. (A) Differentiated THP-1 
macrophages were separated into nuclear and cytosolic fractions and 
analyzed for ASC expression using a monoclonal anti-ASC antibody 
recognizing the PYD of ASC by immunoblot. Blots were stripped and 
re-probed with antibodies for the cytosolic GAPDH and nuclear Lamin 
A to control for fractionation efficiency. (B) THP-1 lysates were ana-
lyzed by immunoblot for ASC expression using antibodies recognizing 
the PYD, the linker, and the CARD, respectively. (C) Lysates from PMA-
differentiated and LPS-treated (300 ng/ml) THP-1 cells and J774A1 cells 
were separated by SDS/PAGE and immunoblotted with a PYD-specific 
anti-ASC antibody (AL177). (D) Lysates of human peripheral blood 
macrophages (PBM) that were left untreated, or treated with LPS for 
the indicated times, were immunoblotted for ASC. (E) PMA-differenti-
ated THP-1 cells were treated with LPS (300 ng/ml) for the indicated 
times and analyzed by RT-PCR for ASC transcripts using the primer 
pairs pr-1 (ASC, 299 bp; ASC-b, 242 bp), pr-2 (ASC-c, 66 bp), and pr-3 
(ASC and ASC-b, 128 bp; ASC-d, 100 bp). A short exposure (upper pan-
el) and long exposure (middle panel) is shown, because of the relative 
low abundance of ASC-d transcripts. A β -actin primer pair (533 bp, 
lower panel) was used as a control.Bryan et al. Journal of Inflammation 2010, 7:23
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distribution (Figure 3, 3rd panel), suggesting that either
the linker is required for ASC self-aggregation and
nuclear import, or some degree of flexibility provided by
t h e  l i n k e r  i s  r e q u i r e d  f o r  n u c l e a r  l o c a l i z a t i o n  o f  A S C .
ASC-c was also found exclusively in the cytoplasm. How-
ever, it oligomerized into long, filamentous structures,
referred to as death filaments, which are also observed
when the CARD or PYD of ASC is expressed by itself
(Figure 3, 4th panel) [47]. ASC-d localized primarily dif-
fuse to the cytosol (Figure 3, 5th panel). These results sug-
gest that the linker region of ASC is required for efficient
self-aggregation.
ASC, ASC-b, ASC-c and ASC-d exhibit differences in their 
ability to co-localize with other inflammasome 
components
ASC functions as an adaptor by interacting with NLRPs
by PYD-PYD and with caspase 1 by CARD-CARD inter-
action, which are both essential to form inflammasomes,
and all three proteins co-localize to aggregates [37]. We
therefore tested the ability of the ASC isoforms to func-
tion as an inflammasome adaptor. HEK293 cells were co-
transfected with a constitutively active GFP-tagged
NLRP3R260W mutant and each myc-epitope tagged ASC
isoform, immunostained with myc-specific antibodies
and analyzed for co-localization by immunofluorescence
microscopy. As previously shown, full-length ASC and
NLRP3R260W co-localized in the perinuclear aggregates,
when co-transfected (Figure 4A, 1st panel). As expected,
ASC-b, which still retains a fully intact PYD, also co-
localized with NLRP3R260W. Co-expression of NLRP3
caused ASC-b to relocate from its diffuse cytosolic local-
i z a t i o n  t o  f o r m  a g g r e g a t e s  w i t h  N L R P 3  ( F i g u r e  4 ,  2 nd
panel). NLRP3 or NLRP3R260W expression alone does not
cause NLRP3 aggregation (data not shown). However,
while these aggregates did exhibit a perinuclear localiza-
tion, they were not as small and condensed as those
observed with ASC. As expected due to lacking an intact
PYD, neither ASC-c nor ASC-d was able to co-localize
with NLRP3R260W (Figure 4, 3rd and 4th panel).
Since ASC bridges NLRs with caspase 1, we next evalu-
ated the capability of the ASC isoforms to interact with
caspase 1. Because activation of caspase 1 would result in
proteolytic cleavage of the CARD of pro-caspase 1, we
expressed the C285A catalytically inactive mutant. We
transiently co-transfected HEK293 cells with a GFP-pro-
caspase 1C285A fusion protein and each of the ASC iso-
forms, which were immunostained as above and analyzed
by fluorescence microscopy. As previously shown, ASC
did co-localize with caspase 1 into the characteristic
aggregates (Figure 4B, 1st panel) [15]. Also ASC-b, and
ASC-c, which both contain an intact CARD, co-localized
with pro-caspase 1, though this did not cause aggregation
of ASC, suggesting that pro-caspase 1 is not sufficient to
cause aggregation of ASC in the absence of an NLR (Fig-
ure 4B, 2nd and 3rd panel). ASC-b retained the diffuse
Figure 2 Three novel ASC isoforms. (A) Clustal W alignment of ASC, ASC-b, ASC-c and ASC-d. ASC consists of a PYD, linker, and CARD, while ASC-b 
displays an in frame deletion of amino acids 93 to 111, corresponding to the complete linker region. ASC-c lacks amino acids 26 to 85 corresponding 
to helices 3 to 6 of the ASC-PYD, and in ASC-d amino acids 36-195 are replaced with 69 unrelated amino acids due to a frame shift resulting in the 
deletion of nucleotides 107 to 134 in ASC-d. (B) Schemata showing the domain structure of the ASC isoforms. (C) Myc-tagged ASC, ASC-b, ASC-c and 
ASC-d were transiently transfected into HEK293 cells and expression of ASC proteins with the predicted molecular weight was verified by immunoblot 
using anti-myc antibodies.Bryan et al. Journal of Inflammation 2010, 7:23
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cytosolic localization pattern that it exhibited when
expressed alone. Furthermore, it only co-localized with
cytoplasmic caspase 1, as it was excluded from the
nucleus. ASC-c co-localized with caspase 1 in the long fil-
amentous structures formed by ASC-c. In contrast, ASC-
d did not co-localize with pro-caspase 1, as expected due
to the lack of the CARD (Figure 4B, 4th panel).
ASC co-localizes with ASC-b and ASC-c
One of the mechanisms by which inflammasome assem-
bly is regulated is through competitive PYD-PYD and
CARD-CARD interactions between PYD-only proteins
(POPs) or CARD-only proteins (COPs) with ASC, cas-
pase 1 and NLRs [36]. Previous studies demonstrated that
ASC can self-oligomerize via its CARD or PYD [40,48],
we wanted to explore the possibility that the truncated
ASC isoforms, ASC-b and ASC-c, could impair the
inflammasome adaptor function of ASC. Co-expression
of ASC with ASC-b resulted in the co-localization of both
proteins in the perinuclear aggregates. However, the
aggregates differed from those assembled by expression
of ASC, and resulted in the formation of large, irregularly
shaped perinuclear aggregates, rather than the small, cir-
cular structures formed by ASC a alone (Figure 5, 1st
panel). Co-expression of ASC with ASC-c also altered its
subcellular localization pattern. Instead of the long fila-
mentous structures formed by ASC-c, co-expression of
ASC caused the recruitment of ASC-c to the perinuclear
ASC aggregates. However, unlike those observed upon
co-expression with ASC-b, these aggregates maintained
all of the previously identified characteristics of ASC
aggregates (Figure 5, 2nd panel). However, there is also
notably less efficient self aggregation of ASC in the pres-
ence of ASC-c, further suggesting that ASC-c potentially
interferes with ASC oligomerization. These results indi-
cate that the shorter isoforms can co-localize with ASC
causing their recruitment to the ASC formed aggregate.
Distinct ASC isoforms can either activate or inhibit 
inflammasome-mediated maturation of IL-1β
Because ASC is essential for inflammasome formation
and maturation and release of IL-1β in macrophages, we
next determined how the different ASC isoforms impact
inflammasome activity. We reconstituted NLRP3 inflam-
masomes in HEK293 cells, which lack endogenous
expression of inflammasome components, but active
inflammasomes can be formed by transient expression of
the core inflammasome components [37-39]. Cells were
transiently co-transfected with expression plasmids
encoding pro-IL-1β, pro-caspase 1, and each of the ASC
isoforms in the presence or absence of the constitutively
active NLRP3R260W. Culture supernatants were collected
thirty-six hours post-transfection and analyzed for
released IL-1β by ELISA. Only ASC and ASC-b, which
contain both the PYD and the CARD, were able to pro-
mote release of IL-1β into culture supernatants (Figure
6A). Lacking the linker domain reduced the ability of
ASC-b to function as an inflammasome adaptor,
although it contains the necessary PYD and CARD. As
expected, neither ASC-c nor ASC-d was able to generate
mature IL-1β.
The RAW 264.7 mouse macrophage cell line lacks ASC
and is therefore deficient in the processing and release of
IL-1β [49]. To test the two activating ASC isoforms under
more physiological conditions, we stably transfected
RAW264.7 cells with myc-tagged ASC, ASC-b, or an
empty plasmid in an effort to restore the ASC deficiency
in these cells. Control cells, ASC, and ASC-b stable cells
were either left untreated or activated with LPS/ATP and
Figure 3 Localization of ASC isoforms. Subcellular localization of 
the myc-tagged ASC isoforms was examined in transiently transfected 
HEK293 cells. Cells were fixed and immunostained with monoclonal 
anti-myc antibodies and Alexa Fluor 488-conjugatetd secondary anti-
bodies. Nuclei and actin were visualized using Topro-3 and Alexa Fluor 
546-conjugated phalloidin, respectively. Images were acquired by la-
ser scanning confocal microscopy, showing from left to right ASC 
(green), nucleus (blue), actin (red) and a merged composite image. The 
panels show ASC (1st and 2nd panels), ASC-b (3rd panel), ASC-c (4th pan-
el), ASC-d (5th panel), and vector control (6th panel).Bryan et al. Journal of Inflammation 2010, 7:23
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culture supernatants were analyzed for secreted IL1β by
ELISA. As previously shown, control cells did not process
and release IL-1β in response to LPS and ATP. However,
restoring ASC or ASC-b expression did result in a limited
increase in IL-1β secretion in response to LPS/ATP, com-
pared to resting cells (Figure 6B). As shown above in our
inflammasome reconstitution system, also stable expres-
sion of ASC-b is less potent as inflammasome adaptor
compared to ASC. Expression of ASC and ASC-b was
confirmed by immunoblot using myc-specific antibodies
(Figure 6B, insert).
Since we showed above that ASC-c and ASC-d are
unable to function as inflammasome adaptor, but at least
ASC-c is capable of co-localizing with caspase 1, we
tested, whether ASC-c can interfere with the function of
ASC as inflammasome adaptor by competing for caspase
1. We used the NLRP3 inflammasome reconstitution
assay and transfected either ASC with empty vector,
ASC-b, ASC-c, or ASC-d, in addition to pro-IL-1β, pro-
caspase 1 and NLRP3R260W, and analyzed the culture
supernatants for IL-1β as above. Co-transfection of ASC
along with ASC-b caused a reduction of IL-1β release,
likely because in some inflammasomes the less potent
ASC-b is incorporated. As expected, co-transfection of
ASC-c did significantly reduce IL-1β levels in the super-
natant, suggesting that ASC-c might function similar as a
CARD-only protein (COP). However, co-transfection of
ASC-d did not significantly affect the previously charac-
terized function of ASC, as determined by the similar lev-
els of IL-1β detected in the supernatant (Figure 6C),
indicating that generation of different isoforms of ASC
have the potential to differentially regulate inflam-
masome activity. To further investigate the effect of ASC-
Figure 4 Localization of ASC isoforms, NLRP3, and caspase 1. ASC isoforms were transiently co-transfected into HEK293 cells with GFP-tagged 
NALP3R260W (A) or GFP-tagged pro-caspase 1C285A (B). Cells were fixed and immunostained with polyclonal anti-myc (Santa Cruz Biotechnology) and 
Alexa Fluor 546-conjugated secondary antibodies (Invitrogen). Topro-3 was used to visualize the nucleus. All images were acquired using laser scan-
ning confocal microscopy with a 100x oil-immersion objective. Panels from left to right show ASC (red), NLRP3 or pro-caspase-1 (green), nucleus 
(blue), and a merged composite image.
Figure 5 Co-localization of ASC with ASC-b and ASC-c. HEK 293 
cells were transiently co-transfected with HA-tagged ASC and myc-
tagged ASC-b (1st panel) or ASC-c (2nd panel). Cells were fixed and im-
munostained with monoclonal anti-myc (Millipore) and polyclonal 
anti-HA (Abcam) antibodies, and Alexa Fluor-488 and -546 conjugated 
secondary antibodies (Invitrogen), respectively. Topro-3 was used to 
visualize the nucleus. All images were acquired using laser scanning 
confocal microscopy with a 100× oil-immersion objective. Panels from 
left to right show ASC-b/ASC-c (green), ASC (red), nucleus (blue) and a 
merged composite image. An arrow points to the aggregate.Bryan et al. Journal of Inflammation 2010, 7:23
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Figure 6 Distinct ASC isoforms can function as either activating or inhibitory inflammasome adaptor. (A) Inflammasomes were reconstituted 
in HEK293 cells by transient transfection of pro-IL-1β, pro-caspase 1, ASC, ASC-b, ASC-c, ASC-d, in the absence (black bars) or presence (gray bars) of 
the constitutive active NLRP3R260W, as indicated. Culture supernatants were analyzed for secreted IL-1β by ELISA 36 hours post transfection. (B) The 
ASC deficient RAW264.7 mouse macrophage cell line was stably transfected with empty vector, myc-tagged ASC, or myc-tagged ASC-b and analyzed 
for IL-1β release in resting cells (black bars) and following LPS (300 ng/ml)/ATP (5 mM) activation (gray bars). (C) Inflammasomes were reconstituted 
in HEK293 cells as shown in Figure 6A. Secreted IL-1β was analyzed by ELISA. All experiments were performed in triplicates (n = 3, +/- SD). (D) Control 
THP-1 cells (Ctrl) or THP-1 cells stably expressing high levels of ASC-c (#1) or low levels of ASC-c (#2) were treated with LPS (300 ng/ml) for 16 hours 
and analyzed for IL-1β release. Expression of ASC-c was determined by immunoblot. (E) Control J774A1 cells (Ctrl) or J774A1 cells stably expressing 
ASC-c were treated with LPS (300 ng/ml) for 16 hours, pulsed with 3 mM ATP for 15 minutes and analyzed for IL-1β release. Experiments in D and E 
were performed in triplicates (n = 2, +/- SD). Expression of ASC-c was determined by immunoblot. Note that the lysates from THP-1 and J774A1 cells 
were separated on the same gel and are the same exposure time.Bryan et al. Journal of Inflammation 2010, 7:23
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c on inflammasome activity in a relevant cell system, we
generated stable ASC-c expressing human THP-1 mono-
cytic cell lines and mouse J774A1 macrophages by lenti-
viral transduction. THP-1Ctrl  and THP-1ASC-c#1  (ASC-c
high expressing cells) and THP-1ASC-c#2  (ASC-c low
expressing cells) were treated with LPS for 16 hours and
culture supernatants were analyzed for IL-1β release.
While THP-1Ctrl  cells robustly responded with IL-1β
release to LPS treatment, THP-1ASC-c#1  cells and to a
much lesser extent THP-1 ASC-c#2 cells were impaired in
IL-1β release, which inversely correlated with the expres-
sion levels of ASC-c, as shown by immunoblot (Figure
6D). J774A1 macrophages require LPS priming followed
by ATP pulsing to secrete IL-1β. As observed for THP-1
cells, also J774A1ASC-c cells, which express an intermedi-
ate level of ASC-c, showed diminished IL-1β release com-
pared to J774A1Ctrl cells following LPS priming and ATP
pulsing (Figure 6E).
Discussion
We report the existence of novel alternative isoforms of
the essential inflammasome adaptor ASC, which have the
potential to differentially regulate inflammasomes. They
either promote (ASC, ASC-b), inhibit (ASC-c) or do not
impact (ASC-d) inflammasome function. However, it still
needs to be established, whether these alternative splice
forms of ASC also contribute to inflammasome activity
on endogenous level. Post-transcriptional modifications,
such as alternative splicing, are common in genes regulat-
ing apoptotic and inflammatory pathways [50,51], and as
much as 94% of all human genes undergo alternative
splicing [52]. Alternative splicing of pre-mRNAs enables
the production of multiple transcripts and proteins with
distinct functions from a single gene. It has been
observed for transcripts encoding several other inflam-
matory adaptor proteins, including the Nod adaptor RIP2
and the TLR/IL-1R adaptor MyD88, IRAK1 and IRAK2,
and results in either activating or inhibitory effects on
downstream signaling [53-56]. Based on annotated
cDNA sequences and antibody mapping, we identified
three novel isoforms of ASC, designated ASC-b, ASC-c,
and ASC-d. Two of these isoforms are most likely gener-
ated through alternative splicing of the ASC pre-mRNA,
while the mechanism giving rise to ASC-d remains
unclear.
The significance of identifying different ASC isoforms
generated by alternative splicing, is their different ability
to function as inflammasome adaptor. While ASC shows
the strongest activity as inflammasome adaptor, ASC-b
shows reduced activity in gene transfer experiments and
when restored in the ASC deficient RAW264.7 mac-
rophage cell line, suggesting that the level of inflam-
masome activity can be regulated by availability of
recruited ASC or ASC-b. ASC-b is commonly co-
expressed with ASC and both function as inflammasome
adaptor, though with different efficacy. Therefore the
observed upregulation of ASC-b following prolonged
LPS treatment in primary human macrophages can be
expected to affect inflammasome activity. In our hands,
ASC-b consistently displayed lower activity compared to
ASC, while Matsushita and colleagues recently showed
an increase in activity of ASC-b. This discrepancy might
result from the system used to address the role of ASC
versus ASC-b. Matsushita and colleagues tested activity
of ASC and ASC-b by co-expressing pro-caspase 1, pro-
IL-1β and either ASC or ASC-b. Our localization data
demonstrated that both equally co-localize with caspase
1 and also interact to a similar extend, as determined bio-
chemically by in vitro GST pull down assay, eliminating
that binding differences to caspase 1 are responsible for
this result (Figure 7). Ectopic expression of ASC resulted
in the formation of perinuclear aggregates, while deletion
of the linker prevented these aggregates and forced ASC-
b to the cytosol. However, co-expression with constitu-
tively active NLRP3R260W or full-length ASC, but not cas-
pase 1 was able to restore aggregate formation, suggesting
that the linker is essential for self-oligomerization of
ASC, but that ASC-b retains the ability to oligomerize
with ASC, NLRs and caspase 1 into inflammasomes.
There is currently no indication that caspase 1 itself
would cause oligomerization of ASC and caspase 1 acti-
vation. The proposed mechanism suggests that NTP-
mediated NLR oligomerization causes aggregation of
ASC and clustering of caspase 1, followed by activation of
caspase 1 by induced proximity, and our results suggest
that NLRs cause ASC aggregation even in the absence of
ASC self-aggregation. We performed this assay in the
Figure 7 ASC and ASC-b interact with pro-caspase 1 with similar 
affinity. Immobilized GST-caspase 1-CARD was incubated with in vitro 
translated and biotinylated ASC or ASC-b and subjected to in vitro GST-
pull down assays using GST-caspase 1-CARD and GST control immobi-
lized to GSH Sepharose, as indicated. Bound proteins were visualized 
with streptavidin-HRP and ECL-Plus detection (Amersham Pharmacia 
Biotech). 10% of the in vitro translated proteins were loaded as 'input".Bryan et al. Journal of Inflammation 2010, 7:23
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presence of a constitutive active NLRP3 mutant to trigger
assembly of inflammasomes, which allowed us to trans-
fect very low concentrations of ASC to prevent any
effects resulting from self-oligomerization of ASC in this
assay. In addition, stable expression of ASC or ASC-b in
RAW264.7 macrophages resulted in low ASC expression
and inflammasomes were activated using LPS/ATP,
which has been recently shown by others and us to cause
aggregation of ASC, NLRP3 and caspase 1 [37,57]. In this
system, the lower activity of ASC-b is consistent with a
recent analysis of the structure of intact ASC, which con-
cluded that the linker region, which is absent in ASC-b, is
required for providing the necessary degree of flexibility
for ASC to facilitate the PYD and CARD interactions
essential for inflammasome formation [58]. Thus, lack of
this flexible linker would significantly impair the capabil-
ity of ASC to simultaneously interact with NLRs and cas-
pase 1, resulting in reduced maturation of IL-1β, which is
consistent with our observation. Nevertheless, ASC-cas-
pase 1 oligomers in the absence of NLRs have been impli-
cated in pyroptosis, suggesting that ASC-b might likely
prevent pyroptosis as well, while still being able to pro-
mote IL-1β and IL-18 maturation [59]. Thus, recruitment
of ASC-b to pyroptosomes might be another mechanism
aside from quickly releasing caspase 1 into the culture
medium to prevent inflammation-induced cell death. In
addition, since ASC-b is cytosolic, either the linker is
directly responsible for nuclear import of ASC or some
degree of flexibility provided by the linker is required for
nuclear localization of ASC.
Ectopic expression of ASC-c resulted in the formation
of long cytosolic filamentous structures, as shown for
other proteins consisting of only a death domain fold,
including ASC-CARD [48,60]. Thus, formation of these
structures was consistent with the domain structure of
ASC-c, which possessed a severely truncated PYD con-
nected by the linker to the CARD. As predicted, ASC-c
retained its ability to co-localize with caspase 1, which
was also recruited into the filaments, while it was not
capable of co-localizing with active NLRP3R260W, which
would require an intact PYD. ASC-c was also able to co-
localize with full-length ASC, likely, because ASC can
dimerize via CARD [48]. ASC-c is essentially comprised
of a CARD and might represent another member of the
natural caspase 1 inhibitory CARD-only protein (COP)
family [36]. Consistently, recruitment of ASC-c signifi-
cantly impaired inflammasome assembly and prevented
maturation of IL-1β, due to lack of an intact PYD, which
is required to bridge NLRs with caspase- 1 in inflam-
masome reconstitution assays as well as following stable
expression in LPS-activated human monocytic THP-1
cells and mouse J774A1 macrophages, indicating that in
contrast to ASC and ASC-b, ASC-c appears to function
as an inhibitory protein. ASC-c is low abundantly
expressed in THP-1 cells, but is highly expressed in
mouse J774A1 cells, where it potentially might offset the
lack of CARD-only proteins in mice [36]. We did not
detect ASC-c under the tested conditions in PBM, but
primary human macrophages express significant lower
ASC levels compared to THP-1 cells, and thus ASC-c
might have been below our detection limit.
The lack of any conserved domain in ASC-d suggests
that it is not functional as inflammasome adaptor. ASC-d
did neither co-localize with caspase 1 nor with active
NLRP3R260W, suggesting that the portion of the PYD
expressed was insufficient to mediate a stable PYD-PYD
interaction. Current models predict PYD-PYD interac-
tions utilizing surfaces on either α-helices 2 and 3 or 1
and 4, suggesting that the α-helices 1 and 2 present in
ASC-d are insufficient to mediate PYD-PYD interactions
[61]. The interaction between ASC and NLRP3 likely
occurs at a positive electrostatic potential surface (EPSP)
patch on the PYD of ASC formed by Lys21, Lys22, Lys26
and Arg41, and a negative EPSP on NLRP3, and ASC-d
lacks Arg41 [62]. We also could not detect endogenous
ASC-d by immunoblot, although it should be detectable
by ASC antibodies recognizing the PYD between amino
acids 1 to 37. One explanation might be that ASC-d is
expressed at very low levels, is not very stable, as indi-
cated from transient expression experiments, is only tem-
porarily expressed, or is not induced by the tested pro-
inflammatory stimuli, but rather by anti-inflammatory
stimuli during the resolution of inflammatory responses,
as recently shown for Nod2. Nod2 functions as a PRR for
MDP, while the dominant negative Nod2-S, which has a
premature stop in the second CARD due to lack of exon
3, is induced specifically by the anti-inflammatory
cytokine IL-10, but repressed by TNF-α and IFN-γ [63].
Alternatively, splicing of ASC-d could be a mechanism to
prevent generation of transcripts encoding activating
ASC proteins [64]. A similar scenario has been recently
proposed for RIP2-β, an alternative splice form of RIP2
lacking any of the known functions of RIP2 [56]. How-
ever, ASC-d could have a yet to be identified function,
which is in part supported by the unique localization pat-
tern observed in some cells. Nevertheless, due to the low
degree of conservation between ASC and ASC-d, the pre-
cise relationship, if any, of ASC-d to ASC is currently elu-
sive and will need further investigation.
To gain more insights into the precise expression pat-
tern and function of ASC isoforms, further expression
profiling following different cytokine treatment will be
needed. One can also assume that different ASC isoforms
might likely impact also other functions of ASC, includ-
ing apoptosis, anoikis, pyroptosis, NF-κB and MAPK
activation, however, this will need further studies. Our
study revealed the existence of alternative splice variants
of ASC, suggesting that the presence of distinct combina-Bryan et al. Journal of Inflammation 2010, 7:23
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tions of ASC splice variants might potentially affect
inflammasome activity at different stages of the inflam-
matory response, and further emphasizes the existence of
multiple regulatory mechanisms controlling IL-1β and
IL-18 processing and release in macrophages and the sig-
nificance of alternative splicing in fine-tuning the inflam-
matory host response.
Conclusions
Generation of different splice variants of ASC potentially
provides a mechanism to regulate assembly and activity
of inflammasomes and thereby release of IL-1β and IL-18
during the inflammatory host response. Expression of
different ratios of activating and inhibitory isoforms of
ASC might promote inflammation at early stages of
infections and tissue damage, but potentially also allows
to terminate these reactions during the resolution phase.
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